MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lipocine (LPCN) Ownership - Who owns Lipocine?

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Profile

Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
61.07M
P/E Ratio
N/A
Total Cash
15.13M
Projected Growth
N/A
Total Debt
1.48M
Revenue
4.32M
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
2.73
Total Debt/Equity
N/A
Revenue/Share
0.79 USD as % of share price

Fundamentals

LPCN
Capitalization
61.1M
P/E Ratio
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
15.1M
Total Cash/Share
2.73
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.79%
Revenue
4.32M
ROE
N/A
Book Value
14.1M
P/B Ratio
4.32
Cash Flow
N/A
Earnings
-1.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.87K
Current Ratio
8.25
Current Revenue Per Employee
7160.88
Dividends Per Share - Security
N/A
EBITDA
-6.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
-243.06
Revenue To Assets
-29.78
Shares Held By Institutions
2.47M
Shares Outstanding - Current
5.55M
Total Liabilities
1.93M
Total Volume MTD
N/A
Value
N/A
Gain YTD
36.986
View a ticker or compare two or three
LPCN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com